Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 370368, 7 pages
http://dx.doi.org/10.1155/2014/370368
Research Article

Inhibitory Effects of Edaravone in β-Amyloid-Induced Neurotoxicity in Rats

1Department of Neurology, Linyi People’s Hospital, Linyi City, Shandong 276000, China
2Department of Out-Patient, Yulin Teacher’s College Hospital, Yulin, Guangxi 537000, China
3Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangdong 510120, China

Received 16 January 2014; Accepted 24 February 2014; Published 2 April 2014

Academic Editor: Jin-Tai Yu

Copyright © 2014 Feng He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Suzuki, T. Kazui, H. Terada et al., “Experimental study on the protective effects of edaravone against ischemic spinal cord injury,” Journal of Thoracic and Cardiovascular Surgery, vol. 130, no. 6, pp. 1586–1892, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Cohen, “Emerging therapies for relapsing multiple sclerosis,” Archives of Neurology, vol. 66, no. 7, pp. 821–828, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Nakamura, Y. Kuroda, S. Yamashita et al., “Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage,” Stroke, vol. 39, no. 2, pp. 463–469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Aoki, M. Nishimura, H. Kataoka, R. Ishibashi, K. Nozaki, and N. Hashimoto, “Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox-/- mice,” Laboratory Investigation, vol. 89, no. 7, pp. 730–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Itoh, T. Satou, S. Nishida, M. Tsubaki, S. Hashimoto, and H. Ito, “The novel free radical scavenger, edaravone, increases neural stem cell number around the area of damage following rat traumatic brain injury,” Neurotoxicity Research, vol. 16, no. 4, pp. 378–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Itoh, T. Satou, S. Nishida et al., “Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats,” Neurochemical Research, vol. 35, no. 2, pp. 348–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Dohi, K. Satoh, Y. Mihara et al., “Alkoxyl radical-scavenging activity of edaravone in patients with traumatic brain injury,” Journal of Neurotrauma, vol. 23, no. 11, pp. 1591–1599, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Ito, R. Wate, J. Zhang et al., “Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice,” Experimental Neurology, vol. 213, no. 2, pp. 448–455, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Yoshino and A. Kimura, “Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (phase II study),” Amyotrophic Lateral Sclerosis, vol. 7, no. 4, pp. 247–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. W. J. Yuan, T. Yasuhara, T. Shingo et al., “Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons,” BMC Neuroscience, vol. 9, article 75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Xiong, J. Xiong, G. Khare et al., “Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease,” PLoS ONE, vol. 6, no. 6, Article ID e20677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Kaur and E.-A. Ling, “Antioxidants and neuroprotection in the adult and developing central nervous system,” Current Medicinal Chemistry, vol. 15, no. 29, pp. 3068–3080, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. G. L. Zhang, W. G. Zhang, Y. Du et al., “Edaravone ameliorates oxidative damage associated with Aβ25-35 treatment in PC12 cells,” Journal of Molecular Neuroscience, vol. 50, no. 3, pp. 494–503, 2013. View at Publisher · View at Google Scholar
  14. Y. E. Shen, Y. Wang, G. C. Yu, C. Liu, Z. Y. Zhang, and L. M. Zhang, “Effects of edaravone on amyloid-β precursor protein processing in SY5Y-APP695 cells,” Neurotoxicity Research, vol. 24, no. 2, pp. 139–147, 2013. View at Publisher · View at Google Scholar
  15. F. He, P. Luan, R. He et al., “Effect of Edaravone on Aβ1-40 induced enhancement of voltage-gated calcium channel current,” CNS Neuroscience & Therapeutics, vol. 18, no. 1, pp. 89–90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Everse and P. W. Coates, “Neurodegeneration and peroxidases,” Neurobiology of Aging, vol. 30, no. 7, pp. 1011–1025, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Lynch, R. A. Cherny, and A. I. Bush, “Oxidative processes in Alzheimer's disease: the role of Aβ-metal interactions,” Experimental Gerontology, vol. 35, no. 4, pp. 445–451, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Akaishi, K. Nakazawa, K. Sato, H. Saito, Y. Ohno, and Y. Ito, “Hydrogen peroxide modulates whole cell Ca2+ currents through L-type channels in cultured rat dentate granule cells,” Neuroscience Letters, vol. 356, no. 1, pp. 25–28, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Hudasek, S. T. Brown, and I. M. Fearon, “H2O2 regulates recombinant Ca2+ channel α1C subunits but does not mediate their sensitivity to acute hypoxia,” Biochemical and Biophysical Research Communications, vol. 318, no. 1, pp. 135–141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Chen, C. J. Lui, M. Tang et al., “Action of β-amyloid peptide1-40 on IHVA and its modulation by ginkgolide B,” Acta Physiologica Sinica, vol. 58, no. 1, pp. 14–20, 2006. View at Google Scholar
  21. L.-M. He, L.-Y. Chen, X.-L. Lou, A.-L. Qu, Z. Zhou, and T. Xu, “Evaluation of β-amyloid peptide 25-35 on calcium homeostasis in cultured rat dorsal root ganglion neurons,” Brain Research, vol. 939, no. 1-2, pp. 65–75, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Davidson, L. Shajenko, and T. S. Donta, “Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells,” Brain Research, vol. 643, no. 1-2, pp. 324–327, 1994. View at Google Scholar · View at Scopus
  23. M. Yu, S. Li, W. Leng, H. Chen, Y. Wu, and L. Yan, “Protective effects of MCI-186 on oxidative damage in a cell model of Alzheimer's disease,” Neural Regeneration Research, vol. 5, no. 16, pp. 1226–1230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. H. Wang, L. D. Zhao, G. R. Jin, Y. Liu, and T. Shi, “Effects of Edaravone on the expressions of Aβ, Tau and GFAP to the brain of vascular dementia in rat,” Chinese Journal of Neuroanatomy, vol. 27, no. 2, pp. 203–208, 2011. View at Google Scholar
  25. S. Zhou, G. Yu, L. Chi et al., “Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats,” Neurotoxicology, vol. 38, pp. 136–145, 2013. View at Google Scholar
  26. Y. Yan, K. Gong, T. Ma et al., “Protective effect of edaravone against Alzheimer's disease-relevant insults in neuroblastoma N2a cells,” Neuroscience Letters, vol. 531, no. 2, pp. 160–165, 2012. View at Google Scholar
  27. Z. Y. Zhao, P. Luan, S. X. Huang et al., “Edaravone protects HT22 neurons from H2O2-induced apoptosis by inhibiting the MAPK signaling pathway,” CNS Neuroscience & Therapeutics, vol. 19, no. 3, pp. 163–169, 2013. View at Google Scholar